Health

Datalchemy, as part of a consortium led by the UP group and Institut Mines-Télécom, has centralized, cleaned, anonymized and enriched heterogeneous data from multiple aid organizations to train and validate neural network models capable of automatically detecting the increased risk of loss of autonomy among beneficiaries.

Datalchemy supports Chipiron, an innovative start-up whose mission is “to put an end to cancer thanks to scalable MRI technologies”.

Datalchemy was called in to help CPAM identify relevant data, establish a working methodology guaranteeing the confidentiality of customer data, and develop a machine learning algorithm to target beneficiaries.